Deng R, Zheng X, Lu Z, Yuan M, Meng Q, Wu T
World J Gastrointest Oncol. 2024; 16(11):4354-4368.
PMID: 39554751
PMC: 11551631.
DOI: 10.4251/wjgo.v16.i11.4354.
Somri-Gannam L, Meisel-Sharon S, Hantisteanu S, Bar-Noy T, Sigal E, Groisman G
Front Oncol. 2024; 14:1410447.
PMID: 39450263
PMC: 11499063.
DOI: 10.3389/fonc.2024.1410447.
Hissong E, Bhinder B, Kim J, Ohara K, Ravichandran H, Al Assaad M
Res Sq. 2024; .
PMID: 39108491
PMC: 11302706.
DOI: 10.21203/rs.3.rs-4751101/v1.
Sang Q, Yang L, Zhao H, Zhao L, Xu R, Liu H
BMC Womens Health. 2024; 24(1):429.
PMID: 39068426
PMC: 11282678.
DOI: 10.1186/s12905-024-03237-2.
Dang Q, Zuo L, Hu X, Zhou Z, Chen S, Liu S
Cancer Med. 2024; 13(14):e70041.
PMID: 39054866
PMC: 11272957.
DOI: 10.1002/cam4.70041.
Integrated analysis of tertiary lymphoid structures and immune infiltration in ccRCC microenvironment revealed their clinical significances: a multicenter cohort study.
Wang Y, Chen W, Zhou W, Dong K, Zuo L, Xu D
J Immunother Cancer. 2024; 12(6).
PMID: 38908856
PMC: 11331356.
DOI: 10.1136/jitc-2023-008613.
VDR is a potential prognostic biomarker and positively correlated with immune infiltration: a comprehensive pan-cancer analysis with experimental verification.
Xia X, Xu F, Dai D, Xiong A, Sun R, Ling Y
Biosci Rep. 2024; 44(5).
PMID: 38639057
PMC: 11065647.
DOI: 10.1042/BSR20231845.
Overcoming cold tumors: a combination strategy of immune checkpoint inhibitors.
Ouyang P, Wang L, Wu J, Tian Y, Chen C, Li D
Front Immunol. 2024; 15:1344272.
PMID: 38545114
PMC: 10965539.
DOI: 10.3389/fimmu.2024.1344272.
Unique characteristics of the tumor immune microenvironment in young patients with metastatic colorectal cancer.
Griffith B, Lazarus J, McGue J, Krishnan S, DAngelica M, Shia J
Front Immunol. 2023; 14:1289402.
PMID: 38152402
PMC: 10751347.
DOI: 10.3389/fimmu.2023.1289402.
Dissecting the role of the gut microbiome and fecal microbiota transplantation in radio- and immunotherapy treatment of colorectal cancer.
Van Dingenen L, Segers C, Wouters S, Mysara M, Leys N, Kumar-Singh S
Front Cell Infect Microbiol. 2023; 13:1298264.
PMID: 38035338
PMC: 10687483.
DOI: 10.3389/fcimb.2023.1298264.
M6A RNA methylation modification and tumor immune microenvironment in lung adenocarcinoma.
Li S, Li Q, Zhang L, Qi Y, Bai H
Biophys Rep. 2023; 9(3):146-158.
PMID: 38028153
PMC: 10648234.
DOI: 10.52601/bpr.2023.220020.
Grid2 interacting protein is a potential biomarker related to immune infiltration in colorectal cancer.
Zhao J, Quan J, Chen W, Xie X
Eur J Med Res. 2023; 28(1):511.
PMID: 37964339
PMC: 10644545.
DOI: 10.1186/s40001-023-01468-x.
A neutrophil extracellular traps-related classification predicts prognosis and response to immunotherapy in colon cancer.
Feng C, Li Y, Tai Y, Zhang W, Wang H, Lian S
Sci Rep. 2023; 13(1):19297.
PMID: 37935721
PMC: 10630512.
DOI: 10.1038/s41598-023-45558-6.
Bioinformatics analysis and experimental validation identified HMGA2/microRNA-200c-3p/LSAMP/Wnt axis as an immunological factor of patients with colorectal cancer.
Xu X, Gong C, Wang Y, Yin Z, Wang X, Hu Y
Am J Cancer Res. 2023; 13(9):3898-3920.
PMID: 37818072
PMC: 10560921.
Immune microenvironment and lymph node yield in colorectal cancer.
Lee S, Pankaj A, Neyaz A, Ono Y, Rickelt S, Ferrone C
Br J Cancer. 2023; 129(6):917-924.
PMID: 37507544
PMC: 10491581.
DOI: 10.1038/s41416-023-02372-1.
Laparoscopic-Assisted Colorectal Resection Can Reduce the Inhibition of Immune Function Compared with Conventional Open Surgery: A Retrospective Clinical Study.
Shi B, Tai Q, Chen J, Shi X, Chen G, Yao H
J Clin Med. 2023; 12(6).
PMID: 36983320
PMC: 10053238.
DOI: 10.3390/jcm12062320.
"Cold" colorectal cancer faces a bottleneck in immunotherapy.
Liu J, Yang M, Bai J, Liu Z, Wang X
World J Gastrointest Oncol. 2023; 15(2):240-250.
PMID: 36908324
PMC: 9994051.
DOI: 10.4251/wjgo.v15.i2.240.
A signature-based classification of lung adenocarcinoma that stratifies tumor immunity.
Zhang X, Jiang D, Li S, Zhang X, Zheng W, Cheng B
Front Oncol. 2023; 12:1023833.
PMID: 36713530
PMC: 9878554.
DOI: 10.3389/fonc.2022.1023833.
Tertiary lymphoid structures are critical for cancer prognosis and therapeutic response.
Zhang Q, Wu S
Front Immunol. 2023; 13:1063711.
PMID: 36713409
PMC: 9875059.
DOI: 10.3389/fimmu.2022.1063711.
Multicenter International Study of the Consensus Immunoscore for the Prediction of Relapse and Survival in Early-Stage Colon Cancer.
Mlecnik B, Lugli A, Bindea G, Marliot F, Bifulco C, Lee J
Cancers (Basel). 2023; 15(2).
PMID: 36672367
PMC: 9856473.
DOI: 10.3390/cancers15020418.